GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Inc (ROCO:6892) » Definitions » Net Interest Income

Taiwan Bio Therapeutics (ROCO:6892) Net Interest Income : NT$0.71 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Taiwan Bio Therapeutics Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Taiwan Bio Therapeutics's net interest income for the three months ended in Dec. 2024 was NT$0.89 Mil. Its net interest income for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.71 Mil.

Taiwan Bio Therapeutics Net Interest Income Historical Data

The historical data trend for Taiwan Bio Therapeutics's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taiwan Bio Therapeutics Net Interest Income Chart

Taiwan Bio Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Interest Income
Get a 7-Day Free Trial -0.10 -2.80 -4.24 -2.87 0.46

Taiwan Bio Therapeutics Quarterly Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.32 -0.88 - -0.18 0.89

Taiwan Bio Therapeutics Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Bio Therapeutics Net Interest Income Related Terms

Thank you for viewing the detailed overview of Taiwan Bio Therapeutics's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Taiwan Bio Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Taiwan Bio Therapeutics Inc (ROCO:6892) » Definitions » Net Interest Income
Comparable Companies
ROCO:6580 ROCO:6461 ROCO:6492 ROCO:6748 ROCO:6676 ROCO:4130 ROCO:7808 TPE:1762 ROCO:1295 TPE:6885 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Tiding Avenue, 5th Floor, No. 501, Section 2, Neihu District, Zhubei, TWN, 114744
Website
https://www.twbio-thera.com
Taiwan Bio Therapeutics Inc is a regenerative medicine company specializing in the development of new genetically modified cell drugs. It is providing commissioned development and manufacturing (CDMO/CMO) services and inspection, analysis and development services for cellular medical products.

Taiwan Bio Therapeutics Headlines

No Headlines